Antibodies that target HIV gp120 and methods of use
US12338278B2 · kind B2 · utility
0Cited by
25References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2021 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Apr 14, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.